John Jelovsek, MD
NPI 1235192170 · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician · Raleigh, NC
Enrolled with Medicare as Practitioner - Obstetrics/Gynecology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
John Jelovsek, MD is a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider in Raleigh, NC (NPI 1235192170).
Provider details
- NPI number
- 1235192170
- Entity type
- Individual
- Primary specialty
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 86180 (NC)
Specialties & taxonomies
- Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianPrimary207VF0040XLicense 86180 (NC)
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
518 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 104 | $120 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211 | 71 | $15 |
| Pelvic Exam99459 | 59 | $21 |
| Ultrasound Measurement of Bladder Capacity After Voiding51798 | 53 | $10 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 47 | $153 |
| Automated Urinalysis Test81003 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Mirabegronbrand: Myrbetriq | 142 | 39 |
| Estradiol | 111 | 65 |
| Trospium Chloridebrand: Trospium Chloride Er | 29 | — |
| Nitrofurantoin Monohyd/M-Crystbrand: Nitrofurantoin Mono-Macro | 18 | 11 |
| Solifenacin Succinate | 12 | — |
| Estrogens, Conjugatedbrand: Premarin | 11 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$40 across 2 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-04-11
- Last updated
- 2025-09-11
- Certified
- 2025-09-11
Frequently asked questions
- What is John Jelovsek's NPI number?
- John Jelovsek's National Provider Identifier (NPI) is 1235192170, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is John Jelovsek's specialty?
- John Jelovsek is listed in the NPPES registry with a primary specialty of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician (Allopathic & Osteopathic Physicians).
- Where is John Jelovsek located?
- John Jelovsek's practice location on file with NPPES is 1200 Navaho Dr, Raleigh, NC 27609-7443.
- What is John Jelovsek's phone number?
- The practice phone number listed in the NPPES registry for John Jelovsek is (919) 385-1999.
- Does John Jelovsek accept Medicare?
- John Jelovsek is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is John Jelovsek's NPI active?
- Yes — John Jelovsek's NPI (1235192170) is active in the NPPES registry as of the last update on 2025-09-11.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.